OverviewSuggest Edit
Freeline is a biotechnology company focusing on the development and commercialization of liver-directed gene therapies. It developes an Adeno-associated virus gene therapy platform to provide treatments for a range of diseases like hemophilia B, Fabry and Gaucher disease. The company strives to build and advance a pipeline of curative treatments to make a life-changing impact.
| Type | Public | |
| Founded | 2015 | |
| HQ | Stevenage, GB | Map |
| Website | freeline.life | |
| Employee Ratings | More |
Recent NewsAll News
- Freeline Announces Expansion of Executive Leadership
- Freeline Presents Data on its Gaucher Disease and Fabry Disease AAV-Based Gene Therapies at the 17th Annual WORLDSymposium™
- Freeline Therapeutics Updates Clinical Development Plan for its FLT180a Hemophilia B Program
- Freeline to Present Data at the 2021 Virtual Congress of the European Association for Haemophilia and Allied Disorders (EAHAD) and the 17th Annual WORLDSymposium™ 2021
Key People/Management at Freeline
Theresa Heggie
Chief Executive Officer and Director
Amit Nathwani
Founder, Clinical and Scientific Adviser and Director
Brian Silver
Chief Financial Officer & Head of Corporate Development
Martin Andrews
Non-Executive Director
Jan Thirkettle
Chief Development Officer
Markus Hörer
Founder, Chief Technology Officer & Managing Director GmbH
Freeline Office Locations
Freeline has offices in Stevenage, New York and Planegg
Stevenage, GB (HQ)
Gunnels Wood Rd
Stevenage, GB
3rd Floor, Kings Court, London Rd
Planegg, DE
Semmelweisstraße 3
New York, NY, US
180 Varick St 8th Floor
Freeline Financials and Metrics
Freeline Revenue
Market capitalization (24-Feb-2021) | 539.9m |
Closing stock price (24-Feb-2021) | 15.6 |
Cash (30-Sept-2017) | 11.0m |
EV | 528.9m |
Freeline's current market capitalization is $539.9 m.
| GBP | FY, 2016 | FY, 2017 |
|---|---|---|
Cash | 5.3m | 11.0m |
Current Assets | 6.9m | 12.3m |
| FY, 2016 | |
|---|---|
Financial Leverage | 1.2 x |
Freeline Cybersecurity Score
Freeline Online and Social Media Presence
Freeline's Trends
Freeline News and Updates
February 16, 2021
Freeline Announces Expansion of Executive Leadership
Michael J. Parini joins from Vertex as President and Chief Operating Officer complementing recent General Counsel and Investor Relations appointments
February 08, 2021
Freeline Presents Data on its Gaucher Disease and Fabry Disease AAV-Based Gene Therapies at the 17th Annual WORLDSymposium™
Data demonstrate potential of FLT201 to deliver sustained levels of β-glucocerebrosidase (GCase) variant 85, a proprietary engineered GCase that penetrates target tissues in Gaucher disease
February 08, 2021
Freeline Therapeutics Updates Clinical Development Plan for its FLT180a Hemophilia B Program
Targeting initiation of dose confirmation trial by end of 2021 with data readout by end of 2022
January 26, 2021
Freeline to Present Data at the 2021 Virtual Congress of the European Association for Haemophilia and Allied Disorders (EAHAD) and the 17th Annual WORLDSymposium™ 2021
LONDON, Jan. 26, 2021 (GLOBE NEWSWIRE) -- Freeline Therapeutics Holdings plc (Nasdaq: FRLN) (the “Company” or “Freeline”), a clinical-stage, fully integrated, next generation, systemic AAV-based gene therapy company with the ambition of transforming the lives of patients suffering from inherited s…
January 04, 2021
Freeline to participate at Conferences during January 2021
LONDON, Jan. 04, 2021 (GLOBE NEWSWIRE) -- Freeline Therapeutics Holdings plc (Nasdaq: FRLN) (the “Company” or “Freeline”), a clinical-stage, fully integrated, next generation, systemic AAV-based gene therapy company with the ambition of transforming the lives of patients suffering from inherited s…
December 14, 2020
Freeline Reports Updated Data From Phase 1/2 B-AMAZE Trial in Hemophilia B
Updated dose-ranging data demonstrate potential for full normalization of FIX activity
Freeline Frequently Asked Questions
When was Freeline founded?
Freeline was founded in 2015.
Who are Freeline key executives?
Freeline's key executives are Theresa Heggie, Amit Nathwani and Brian Silver.
How many employees does Freeline have?
Freeline has 326 employees.
Who are Freeline competitors?
Competitors of Freeline include Alerion, Pantherna Therapeutics and Repair Biotechnologies.
Where is Freeline headquarters?
Freeline headquarters is located at Gunnels Wood Rd, Stevenage.
Where are Freeline offices?
Freeline has offices in Stevenage, New York and Planegg.
How many offices does Freeline have?
Freeline has 4 offices.
Learn about Craft real-time company insights
Receive alerts for 300+ data fields across thousands of companies